Efficacy and safety of single-agent axitinib (AG-013736; AG) in patients (pts) with advanced non-small cell lung cancer (NSCLC): a phase II trial

被引：0
|
作者：
Von Pawel, J. [1 ]
Larson, T. [2 ]
Ou, S. I. [3 ]
Limentani, S. A. [4 ]
Sandler, A. B. [5 ]
Vokes, E. E. [6 ]
Kim, S.
Liau, K. F.
Bycott, P. W. [7 ]
Schiller, J. H. [8 ]
机构：
[1] Asklepios Fachklin Lungenkrankheiten, Abt Onkol, Gauting, Germany
[2] Hubert H Humphrey Canc Ctr, Robbinsdale, MN USA
[3] Chao Family Comprehens Canc Ctr, Orange, CA USA
[4] Blumenthal Canc Ctr, Carolinas Hematol Oncol Assoc, Charlotte, NC USA
[5] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[6] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[7] Pfizer Inc, San Diego, CA USA
[8] Univ Texas Southwestern, Dallas, TX USA
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71379-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6551
引用
收藏
页码：373 / 373
页数：1
相关论文
共 50 条
  • [41] A phase I/II study of AG-013736, an oral anti-angiogenesis agent, in combination with docetaxel in patients (pts) with metastatic breast cancer (MBC)
    Rugo, HS
    Stopeck, A
    Badorf, A
    Pithavala, YK
    Steinfeldt, HM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S62 - S62
  • [42] Single-agent chemotherapy for non-small cell lung cancer
    Eckardt, J
    LUNG CANCER, 2003, 41 : S17 - S22
  • [43] A phase II study of single-agent gemcitabine as a second-line treatment in advanced non-small cell lung cancer
    Cho, KH
    Song, YB
    Choi, IS
    Cho, EH
    Choi, JW
    Ahn, YM
    Roh, YH
    Nam, SH
    Kim, BS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (01) : 50 - 54
  • [44] Results of a phase II study of single-agent sunitinib in elderly non-small cell lung cancer patients.
    Reynolds, C.
    Spira, A. I.
    Gluck, W. L.
    Pluenneke, R. E.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non-Small-Cell Lung Cancer
    Blumenschein, George R., Jr.
    Gatzemeier, Ulrich
    Fossella, Frank
    Stewart, David J.
    Cupit, Lisa
    Cihon, Frank
    O'Leary, James
    Reck, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4274 - 4280
  • [46] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Wozniak, A. J.
    Kalemkerian, G. P.
    Gadgeel, S. M.
    Schneider, B. J.
    Valdivieso, M.
    Venkatramanamoorthy, R.
    Hackstock, D. M.
    Chen, W.
    Heilbrun, L. K.
    Ruckdeschel, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC).
    Drilon, Alexander E.
    Camidge, D. Ross
    Ou, Sai-Hong Ignatius
    Clark, Jeffrey William
    Socinski, Mark A.
    Weiss, Jared
    Riely, Gregory J.
    Winter, Maria
    Wang, Sherry C.
    Monti, Katherine
    Wilner, Keith D.
    Paik, Paul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] A PHASE II TRIAL OF PEMETREXED (P), GEMCITABINE (G), AND BEVACIZUMAB (BV) IN UNTREATED PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Wozniak, Antoinette
    Kalemkerian, Gregory
    Gadgeel, Shirish M.
    Ramnath, Nithya
    Schneider, Bryan
    Valdivieso, Manuel
    Smith, Daryn
    Hackstock, Deborah
    Chen, Wei
    Ruckdeschel, John
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1234 - S1235
  • [49] A phase II trial of biweekly administration of vinorelbine (V) and gemcitabine (G) in elderly patients (Pts) with advanced non-small cell lung cancer (NSCLC).
    Kimura, H
    Kasahara, K
    Shibata, K
    Shirasaki, H
    Iwasa, K
    Yoshimoto, A
    Kita, T
    Fuzimura, M
    Nakao, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 698S - 698S
  • [50] Phase II clinical trial of kahalalide F (KF) as a second line therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Provencio, Mariano
    Izquierdo, Angel
    Vinolas, Nuria
    Paz-Ares, Luis
    Feliu, Jaime
    Constenla, Manuel
    de las Heras, Begona
    Erustes, Mercedes
    Izquierdo, Miguel A.
    Rosell, Rafael
    ANNALS OF ONCOLOGY, 2006, 17 : 225 - 225
12345